NO973241L - Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av hyperlipoproteinemi, hypertriglyceridemi, hyperlipidemi eller hyperkolesterolemi, eller arteriosklerose, eller for antikoagulativ b - Google Patents
Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av hyperlipoproteinemi, hypertriglyceridemi, hyperlipidemi eller hyperkolesterolemi, eller arteriosklerose, eller for antikoagulativ bInfo
- Publication number
- NO973241L NO973241L NO973241A NO973241A NO973241L NO 973241 L NO973241 L NO 973241L NO 973241 A NO973241 A NO 973241A NO 973241 A NO973241 A NO 973241A NO 973241 L NO973241 L NO 973241L
- Authority
- NO
- Norway
- Prior art keywords
- treatment
- hypertriglyceridemia
- hypercholesterolemia
- hyperlipidemia
- arteriosclerosis
- Prior art date
Links
- 208000031226 Hyperlipidaemia Diseases 0.000 title abstract 4
- 238000011282 treatment Methods 0.000 title abstract 3
- 206010003210 Arteriosclerosis Diseases 0.000 title abstract 2
- 208000035150 Hypercholesterolemia Diseases 0.000 title abstract 2
- 239000003146 anticoagulant agent Substances 0.000 title abstract 2
- 229940127219 anticoagulant drug Drugs 0.000 title abstract 2
- 208000011775 arteriosclerosis disease Diseases 0.000 title abstract 2
- 208000020346 hyperlipoproteinemia Diseases 0.000 title abstract 2
- 208000006575 hypertriglyceridemia Diseases 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 238000011321 prophylaxis Methods 0.000 title abstract 2
- FNIBSWRSKVEZDZ-UHFFFAOYSA-N 3,4-diphenyl-3,4-dihydro-2h-chromene Chemical class C1OC2=CC=CC=C2C(C=2C=CC=CC=2)C1C1=CC=CC=C1 FNIBSWRSKVEZDZ-UHFFFAOYSA-N 0.000 title 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001302 tertiary amino group Chemical group 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK4395 | 1995-01-13 | ||
| DK4195 | 1995-01-13 | ||
| DK6995 | 1995-01-20 | ||
| DK76695 | 1995-06-30 | ||
| DK76795 | 1995-06-30 | ||
| DK77795 | 1995-06-30 | ||
| PCT/DK1996/000014 WO1996021443A1 (en) | 1995-01-13 | 1996-01-10 | Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of hyperlipoproteinaemia, hypertriglyceridaemia, hyperlipidaemia or hypercholesterolaemia or arteriosclerosis or for anticoagulative treatment |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO973241L true NO973241L (no) | 1997-07-11 |
| NO973241D0 NO973241D0 (no) | 1997-07-11 |
Family
ID=27545138
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO973241A NO973241D0 (no) | 1995-01-13 | 1997-07-11 | Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av hyperlipoproteinemi, hypertriglyceridemi, hyperlipidemi eller hyperkolesterolemi, eller arteriosklerose, eller for antikoagulativ b |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0804189A1 (pt) |
| JP (1) | JPH10511961A (pt) |
| CN (1) | CN1168098A (pt) |
| AU (1) | AU4329296A (pt) |
| BR (1) | BR9606890A (pt) |
| CA (1) | CA2208859A1 (pt) |
| CZ (1) | CZ212397A3 (pt) |
| HU (1) | HUP9800521A3 (pt) |
| IL (1) | IL116745A (pt) |
| NO (1) | NO973241D0 (pt) |
| WO (1) | WO1996021443A1 (pt) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5407955A (en) * | 1994-02-18 | 1995-04-18 | Eli Lilly And Company | Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease |
| US6069175A (en) * | 1996-11-15 | 2000-05-30 | Pfizer Inc. | Estrogen agonist/antagonists treatment of atherosclerosis |
| WO1999048497A1 (en) * | 1998-03-20 | 1999-09-30 | Novo Nordisk A/S | USE OF 3,4-DIPHENYLCHROMANS FOR THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION FOR LOWERING PLASMA LEVELS OF Lp(a) IN A HUMAN OR SUB-HUMAN PRIMATE |
| US7005428B1 (en) | 1998-06-11 | 2006-02-28 | Endorecherche, Inc. | Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| US6465445B1 (en) | 1998-06-11 | 2002-10-15 | Endorecherche, Inc. | Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| US6613083B2 (en) | 2001-05-02 | 2003-09-02 | Eckhard Alt | Stent device and method |
| US8080675B2 (en) | 2004-09-21 | 2011-12-20 | Marshall Edwards, Inc. | Chroman derivatives, medicaments and use in therapy |
| EP1794141B1 (en) | 2004-09-21 | 2011-11-09 | Marshall Edwards, Inc. | Substituted chroman derivatives, medicaments and use in therapy |
| US9708283B2 (en) | 2010-11-01 | 2017-07-18 | Mei Pharma, Inc. | Isoflavonoid compositions and methods for the treatment of cancer |
| SI2953938T1 (en) | 2014-02-07 | 2018-01-31 | Novogen Ltd. | Functionalized benzopyran compounds and their use |
| CN116139125A (zh) | 2015-02-02 | 2023-05-23 | 梅制药公司 | 联合治疗 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1543749A1 (de) * | 1966-02-16 | 1969-12-11 | Merck Ag E | Verfahren zur Herstellung von 3,4-cis-4-Aryl-isoflavanen |
| US5407955A (en) * | 1994-02-18 | 1995-04-18 | Eli Lilly And Company | Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease |
-
1996
- 1996-01-10 CZ CZ972123A patent/CZ212397A3/cs unknown
- 1996-01-10 BR BR9606890A patent/BR9606890A/pt not_active Application Discontinuation
- 1996-01-10 CN CN96191417A patent/CN1168098A/zh active Pending
- 1996-01-10 WO PCT/DK1996/000014 patent/WO1996021443A1/en not_active Ceased
- 1996-01-10 EP EP96900095A patent/EP0804189A1/en not_active Withdrawn
- 1996-01-10 HU HU9800521A patent/HUP9800521A3/hu unknown
- 1996-01-10 CA CA002208859A patent/CA2208859A1/en not_active Abandoned
- 1996-01-10 AU AU43292/96A patent/AU4329296A/en not_active Abandoned
- 1996-01-10 JP JP8521377A patent/JPH10511961A/ja active Pending
- 1996-01-12 IL IL11674596A patent/IL116745A/xx not_active IP Right Cessation
-
1997
- 1997-07-11 NO NO973241A patent/NO973241D0/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR9606890A (pt) | 1997-10-28 |
| AU4329296A (en) | 1996-07-31 |
| HUP9800521A3 (en) | 1999-12-28 |
| CA2208859A1 (en) | 1996-07-18 |
| MX9705214A (es) | 1997-10-31 |
| IL116745A (en) | 1999-12-22 |
| JPH10511961A (ja) | 1998-11-17 |
| WO1996021443A1 (en) | 1996-07-18 |
| CN1168098A (zh) | 1997-12-17 |
| EP0804189A1 (en) | 1997-11-05 |
| IL116745A0 (en) | 1996-05-14 |
| NO973241D0 (no) | 1997-07-11 |
| HUP9800521A2 (hu) | 1998-12-28 |
| CZ212397A3 (en) | 1997-11-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT863875E (pt) | Novos compostos 4-(oxialcoxifenil)-3-oxi-piperidina para o tratamento de insuficiencia cardiaca e renal | |
| NO20003514L (no) | Hypolipidemiske benzothiazepin-forbindelser | |
| NZ325449A (en) | Naphthyl-substituted benzimidazole derivatives as anticoagulants | |
| ATE306261T1 (de) | Antithrombosemittel | |
| BR0215240A (pt) | Derivados de calcona e seu uso no tratamento de doenças | |
| BR9611400A (pt) | "agentes antimicobiano de benzoxazina". | |
| YU56995A (sh) | Soli derivata indola | |
| AP9701041A0 (en) | Pyridylpyrrole compounds. | |
| SE9604786D0 (sv) | New compounds | |
| MX9605741A (es) | Clorhidrato cristalino del (r)-(-)-2-{n-[4-(1,1-dioxido-3-oxo-2,3-dihidro-benzisotiazol-2-il)-butil ]-aminometil} cromano. | |
| ES2147399T3 (es) | Nuevos derivados de 2,3,5-trimetil-4-hidroxianilidas, su preparacion y su aplicacion terapeutica. | |
| NO20050073L (no) | Ringsubstituerte difenylazetidinoner, deres fremstilling, deres anvendelse samt legemidler inneholdende forbindelsene | |
| NO973241L (no) | Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av hyperlipoproteinemi, hypertriglyceridemi, hyperlipidemi eller hyperkolesterolemi, eller arteriosklerose, eller for antikoagulativ b | |
| MX9708696A (es) | Cefalosporinas antibacterianas. | |
| NO971625L (no) | Nye peptider med immunomodulatoriske effekter | |
| NO983178L (no) | Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasaytisk preparat for behandling eller profylakse av menopausesymptomer | |
| DK26289A (da) | Anvendelse af 1,4-disubstitueret piperidinyl til fremstilling af et farmaceutisk praeparat til behandling af insomnia | |
| FI844333L (fi) | 11-substituerade 5h,11h-pyrrolo/2,1-c/ /1,4/benzoxazepiner, foerfarande foer deras framstaellning och deras anvaendning som laekemedel. | |
| DK0701449T3 (da) | Fremgangsmåde til fremstilling af en oral fast dosisform indeholdende diclofenac | |
| NO973340L (no) | Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av fedme | |
| DE69132578D1 (de) | Cephemderivate | |
| NO973242L (no) | Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av idiopatisk eller fysiologisk gynekomasti | |
| DK0660822T3 (da) | Cykliske benzylamino-, benzylamido- og benzylimidoderivater som antipsykotiske midler | |
| BR9610175A (pt) | Composto processo de preparação do composto composição farmacêutica e utilização do composto | |
| ATE181734T1 (de) | N-benzoylmethylsubstituierte paroxetinderivate |